Shariat SF - Search Results

1

Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.

Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Soulières D, Montanari E, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI. Nazzani S, et al. Among authors: shariat sf. Eur Urol Focus. 2020 Mar 15;6(2):298-304. doi: 10.1016/j.euf.2018.09.007. Epub 2018 Sep 25. Eur Urol Focus. 2020. PMID: 30266210

2

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.

Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Shariat SF, et al. Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1. Urology. 2000. PMID: 11068290

3

E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.

Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, Lerner SP. Shariat SF, et al. Urology. 2001 Jan;57(1):60-5. doi: 10.1016/s0090-4295(00)00892-x. Urology. 2001. PMID: 11164145

4

E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP. Byrne RR, et al. Among authors: shariat sf. J Urol. 2001 May;165(5):1473-9. J Urol. 2001. PMID: 11342899

5

Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.

Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Andrews B, et al. Among authors: shariat sf. J Urol. 2002 Mar;167(3):1475-81. J Urol. 2002. PMID: 11832773

6

Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.

Shariat SF, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP. Shariat SF, et al. J Urol. 2003 Mar;169(3):938-42. doi: 10.1097/01.ju.0000043638.89552.ed. J Urol. 2003. PMID: 12576817

7

Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.

Shariat SF, Kim J, Nguyen C, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Urology. 2003 Feb;61(2):359-64. doi: 10.1016/s0090-4295(02)02253-7. Urology. 2003. PMID: 12597948

8

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

Shariat SF, Monoski MA, Andrews B, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Urology. 2003 May;61(5):1053-8. doi: 10.1016/s0090-4295(02)02522-0. Urology. 2003. PMID: 12736046

9

Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.

Singh H, Karakiewicz P, Shariat SF, Canto EI, Nath RK, Kattan MW, Slawin KM. Singh H, et al. Among authors: shariat sf. Urology. 2004 Jun;63(6):1122-7. doi: 10.1016/j.urology.2004.01.016. Urology. 2004. PMID: 15183964 Clinical Trial.

10

Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.

Karakiewicz P, Shariat SF, Naderi A, Kadmon D, Slawin KM. Karakiewicz P, et al. Among authors: shariat sf. Urology. 2005 Jan;65(1):131-5. doi: 10.1016/j.urology.2004.08.054. Urology. 2005. PMID: 15667878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,905 results

Search Page

Filters